Literature DB >> 12109619

Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major.

M F Messina1, F Lombardo, A Meo, M Miceli, M Wasniewska, M Valenzise, C Ruggeri, T Arrigo, F De Luca.   

Abstract

The aim of this prospective study was to evaluate the evolution of glucose tolerance (GT), insulin secretion and peripheral insulin sensitivity during a 3-yr follow-up in a homogenous population consisting of fourteen non-diabetic adults with thalassemia major (TM). All the patients underwent 2 OGTTs with a 3-yr interval and random measurements of fasting glycemia during the entire follow-up. At the time of both OGTTs, peripheral insulin sensitivity was assessed by both homeostatic model assessment (HOMA) index and a novel index derived from the OGTT. At the second OGTT patients exhibited both significantly higher fasting glucose concentrations and enhanced glycemic responses, with greater average glucose areas. GT deterioration over time was accompanied by a reduction of insulin sensitivity, with no concomitant change of insulin secretion. No patient developed diabetes mellitus (DM) during follow-up. To conclude, the natural history of glycometabolic status in TM adults seems to be characterized by a GT deterioration over time, which may probably reflect an increase of insulin resistance. GT deterioration is more evident in patients with the highest responses to the 1st OGTT and particularly in those with pre-existing impaired GT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109619     DOI: 10.1007/bf03345490

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia; with observations on the pathogenesis of the siderosis and fibrosis.

Authors:  J T ELLIS; I SCHULMAN; C H SMITH
Journal:  Am J Pathol       Date:  1954 Mar-Apr       Impact factor: 4.307

2.  Endocrinopathy in thalassaemia major.

Authors:  N McIntosh
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

3.  Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia.

Authors:  C E Jensen; S M Tuck; J Old; R W Morris; A Yardumian; V De Sanctis; A V Hoffbrand; B Wonke
Journal:  Eur J Haematol       Date:  1997-08       Impact factor: 2.997

4.  The euglycemic clamp in patients with thalassaemia intermedia.

Authors:  S Brianda; M Maioli; T Frulio; F Dore; M Longinotti; D Fracasso; S Campus
Journal:  Horm Metab Res       Date:  1987-07       Impact factor: 2.936

5.  Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major.

Authors:  T Arrigo; G Crisafulli; A Meo; M Sturiale; F Lombardo; M Miceli; D Cucinotta; F De Luca
Journal:  J Pediatr Endocrinol Metab       Date:  1998       Impact factor: 1.634

6.  Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.

Authors:  K Zuppinger; B Molinari; A Hirt; P Imbach; E Gugler; O Tönz; R P Zurbrügg
Journal:  Helv Paediatr Acta       Date:  1979

7.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus.

Authors:  S M Haffner; M P Stern; H P Hazuda; J A Pugh; J K Patterson
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245

9.  Factors determining glucose tolerance in patients with thalassemia major.

Authors:  K Dmochowski; D T Finegood; W Francombe; B Tyler; B Zinman
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

10.  Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia.

Authors:  P Cavallo-Perin; G Pacini; F Cerutti; A Bessone; C Condo; L Sacchetti; A Piga; G Pagano
Journal:  Metabolism       Date:  1995-03       Impact factor: 8.694

View more
  7 in total

Review 1.  Iron and diabetes risk.

Authors:  Judith A Simcox; Donald A McClain
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

2.  Quantification of pancreatic iron overload and fat infiltration and their correlation with glucose disturbance in pediatric thalassemia major patients.

Authors:  Jingwen Huang; Jun Shen; Qihua Yang; Ziliang Cheng; Xiaodong Chen; Taihui Yu; Jinglian Zhong; Yun Su; Hua Guo; Biling Liang
Journal:  Quant Imaging Med Surg       Date:  2021-02

3.  The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Saif Al Yaarubi; Nicos Skordis; Doaa Khater; Mohamed El Kholy; Iva Stoeva; Bernadette Fiscina; Michael Angastiniotis; Shahina Daar; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-28       Impact factor: 2.576

Review 4.  Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in patients with thalassemia major in Iran: A meta-analysis study.

Authors:  Milad Azami; Ali Sharifi; Siros Norozi; Akram Mansouri; Kourosh Sayehmiri
Journal:  Caspian J Intern Med       Date:  2017

5.  Long-Term Follow-up of β-Transfusion-Dependent Thalassemia (TDT) Normoglycemic Patients with Reduced Insulin Secretion to Oral Glucose Tolerance Test (OGTT): A Pilot Study.

Authors:  Vincenzo de Sanctis; Ashraf T Soliman; Shahina Daar; Ploutarchos Tzoulis; Salvatore Di Maio; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-03-01       Impact factor: 2.576

6.  Prenatal iron exposure and childhood type 1 diabetes.

Authors:  Ketil Størdal; Harry J McArdle; Helen Hayes; German Tapia; Marte K Viken; Nicolai A Lund-Blix; Margaretha Haugen; Geir Joner; Torild Skrivarhaug; Karl Mårild; Pål R Njølstad; Merete Eggesbø; Siddhartha Mandal; Christian M Page; Stephanie J London; Benedicte A Lie; Lars C Stene
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

7.  Age- and body mass index-dependent relationship between correction of iron deficiency anemia and insulin resistance in non-diabetic premenopausal women.

Authors:  Ali Ozdemir; Can Sevinç; Umut Selamet; Berna Kamaci; Sacide Atalay
Journal:  Ann Saudi Med       Date:  2007 Sep-Oct       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.